| 引用本文：满春霞, 管晓东, 邹武捷, 郭志刚, 马莉莉, 刘伊, 史录文.我国各省药品集中招标采购政策分析和思考[J].中国卫生政策研究,2016,9(7):53-59 |
|
| 我国各省药品集中招标采购政策分析和思考 |
| 投稿时间：2016-04-09 修订日期：2016-06-03 PDF全文浏览 HTML全文浏览 |
| 满春霞1, 管晓东1,2, 邹武捷1, 郭志刚1, 马莉莉1, 刘伊1, 史录文1,2 |
1. 北京大学药学院 北京 100191;
2. 北京大学医药管理国际研究中心 北京 100191 |
| 摘要:目的：为完善我国各省药品集中招标采购工作提供参考和建议。方法：检索收集2015年我国各省药品集中招标采购最新方案、细则、办法等文件，采用文献分析、对比分析和实地调研访谈等方法进行归纳总结。结果与结论：各省招标采购工作进度不一，在招标药品范围、质量层次划分、双信封评审体系和中标产品数量等方面存在较大差异。建议发挥市场机制在药品招标采购中的作用，落实带量采购，构建完备的质量评价体系，加快仿制药一致性评价。 |
| 关键词:集中招标采购 质量层次 带量采购 质量评价 |
| 基金项目:国家自然科学基金青年科学基金（71303011）；国家卫生计生委药物政策与基本药物制度司委托课题 |
|
| Analysis of provincial centralized bidding and procurement of drugs in China |
| MAN Chun-xia1, GUAN Xiao-dong1,2, ZOU Wu-jie1, GUO Zhi-gang1, MA Li-li1, LIU Yi1, SHI Lu-wen1,2 |
1. School of Pharmaceutical Sciences, Peking University, Beijing 100191, China;
2. International Research Center of Medicinal Administration, Peking University, Beijing 100191, China |
| Abstract:Objective: To improve the centralized bidding and procurement of drugs in China.Methods: By using literature review, comparative analysis and field investigation, this study collected and analyzed implementation plans and regulations of the centralized bidding and procurement of drugs in 2015. Results and Conclusions: Progress of centralized bidding procurement practice was mixed and there were differences in the scope of implementation, quality level classification, evaluation system of double envelope bidding, and other aspects among provinces. The government should give full play to the role of medical insurance department in drug procurement and group purchasing, develop a relatively comprehensive drug quality evaluation system, and speed up the evaluation of the consistency of generic drugs. |
| Key words:Centralized bidding procurement Quality level Group purchasing Quality evaluation |
| 摘要点击次数: 2739 全文下载次数: 14 |
|
|
|
|
|
